National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Thyroid. 2022 Dec;32(12):1439-1470. doi: 10.1089/thy.2022.0251. Epub 2022 Dec 8.
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this consensus statement.
甲状腺眼病（TED）仍然是临床医生评估和治疗的挑战。最近出现了新的治疗方法，但它们的具体作用仍在确定中。大多数 TED 患者在接受甲状腺功能亢进治疗和内分泌科医生的治疗时会出现眼部表现。因此，内分泌科医生在诊断、初步管理和选择需要转介至专科治疗的患者方面发挥着关键作用。鉴于需要为负责满足 TED 患者需求的内分泌科医生提供指导，并且需要最大限度地促进国际间知识和实践的交流，美国甲状腺协会和欧洲甲状腺协会联手制定了本共识声明。
